Neurones S.A.

EPA:NRO.PA

45.1 (EUR) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q1
Revenue 402.431372.483368.692338.24327.139290.586289.293270.071254.418256.228253.846246.952243.123240.009245.005225.282221.478203.865195.503178.03177.14174.691168.47480.01980.01977.68377.683
Cost of Revenue 213.088195.324325.029297.717286.027256.013252.926231.607220.418228.498227.084143.974148.118145.468153.457139.123141.431127.644128.738116.248118.616111.491112.29752.60452.60452.69952.699
Gross Profit 189.343177.15943.66340.52341.11234.57336.36738.4643427.7326.762102.97895.00594.54191.54886.15980.04776.22166.76561.78258.52463.256.17727.41527.41524.98424.984
Gross Profit Ratio 0.470.4760.1180.120.1260.1190.1260.1420.1340.1080.1050.4170.3910.3940.3740.3820.3610.3740.3420.3470.330.3620.3330.3430.3430.3220.322
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000
SG&A 140.026128.5882.1122.3491.411.7481.6485.0395.01574.3150.53373.67969.60768.13666.29159.79657.41552.46546.70639.79239.51440.95838.4517.57817.57816.28216.282
Other Expenses 12.26612.168-3.922-3.169-3.784-2.247-3.623-4.009-3.502-1.813-3.6260000000000000000
Operating Expenses 152.292140.7566.0345.5185.1943.9955.2719.0488.5171.8134.15977.82974.22870.76170.2862.53460.9495649.98342.36142.32945.02541.342-19.718-19.718-18.592-18.592
Operating Income 37.05136.40337.62935.00535.91830.57831.09629.41625.48325.91722.60325.24620.56223.30121.00923.64919.06720.31516.86619.37716.42718.1314.7897.6767.6766.3596.359
Operating Income Ratio 0.0920.0980.1020.1030.110.1050.1070.1090.10.1010.0890.1020.0850.0970.0860.1050.0860.10.0860.1090.0930.1040.0880.0960.0960.0820.082
Total Other Income Expenses Net 4.7293.0313.2560.5520.1140.303-1.5130.178-2.343-0.2064.1681.0060.741.5961.8751.5660.6630.5090.8110.6870.7660.8510.9760.3310.3310.3640.364
Income Before Tax 41.7839.43440.88535.55736.03230.88129.58329.59423.1425.71127.32526.25221.30224.89722.88425.21519.7320.82417.67720.06417.19318.98115.7658.0078.0076.7236.723
Income Before Tax Ratio 0.1040.1060.1110.1050.110.1060.1020.110.0910.10.1080.1060.0880.1040.0930.1120.0890.1020.090.1130.0970.1090.0940.10.10.0870.087
Income Tax Expense 12.57910.81210.9259.57510.2438.898.6349.7258.0249.0648.81510.4717.5068.4727.6968.767.1637.456.5137.2766.3717.296.073.1123.1123.0293.029
Net Income 24.523.98925.42122.19122.05219.40418.30217.39413.52414.93615.86313.87912.0814.26813.04214.31410.88511.6419.71711.0639.44210.2668.3044.2694.2693.1563.156
Net Income Ratio 0.0610.0640.0690.0660.0670.0670.0630.0640.0530.0580.0620.0560.050.0590.0530.0640.0490.0570.050.0620.0530.0590.0490.0530.0530.0410.041
EPS 1.010.991.050.920.910.80.760.720.560.620.650.570.50.580.540.590.450.480.40.460.390.430.340.180.180.130.13
EPS Diluted 1.010.981.050.910.910.80.750.720.560.610.650.570.50.590.540.590.450.480.40.460.390.430.340.180.180.130.13
EBITDA 41.2940.90545.13842.95643.37338.69637.78336.68733.24333.6429.93629.36524.34327.75124.98227.6822.77123.41119.04521.74218.61520.25616.778.6278.6277.2227.222
EBITDA Ratio 0.1030.110.1220.1270.1330.1330.1310.1360.1310.1310.1180.1190.10.1160.1020.1230.1030.1150.0970.1220.1050.1160.10.1080.1080.0930.093